Evidence map›Paper›PMID 30450529›Full record

ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2019

Unmet Needs in the Management of Type 2 Diabetes Mellitus Patients Starting Insulin Therapy with Basal or Premix Insulin in Routine Clinical Practice in Serbia.

Teodora M Beljić Živković, Boris J Đinđić, Dušica Ž Šuluburić Toljić, Koviljka T Milenković Vulović, Dragana L Udovičić, Dragan Z Zdravković

Open access · goldAbstract read
In one paragraph

Article in Diabetes therapy : research, treatment and education of diabetes and related disorders, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Teodora M Beljić ŽivkovićDivision of Endocrinology, Diabetes and Metabolic Disorders, "Zvezdara" University Medical Center, Belgrade University School of Medicine, Belgrade, Serbia. dorabeljic@beotel.net.ORCID http://orcid.org/0000-0002-0730-8185
Boris J ĐinđićFaculty of Medicine, Clinic of Cardiology, Institute of Pathophysiology, Clinical Center Niš, Niš, Serbia.
Dušica Ž Šuluburić ToljićGeneral Hospital Čačak, Čačak, Serbia.
Koviljka T Milenković VulovićGeneral Hospital Čačak, Čačak, Serbia.
Dragana L UdovičićHealth Center Užice, Užice, Serbia.
Dragan Z ZdravkovićSanofi, Belgrade, Serbia.
Center for Health, Exercise and Sport Sciences · RSKliničko Bolnički Centar Zvezdara · RSUniversity of Nis · RS

Funding

Sanofi Serbia 1
6 · The paper itself

Abstract

introductionType 2 diabetes mellitus (T2DM) is a progressive disease with declining beta cell function, ultimately necessitating insulin therapy. Timely introduction of adequate insulin improves management of diabetes. The aim of this study was to evaluate the unmet needs in the management of T2DM patients recently initiated on insulin therapy in routine clinical practice in Serbia.

methodsThe NEED study was a cross-sectional, observational, multicenter, real-world study conducted in Serbia, involving 26 physicians, endocrinologists, treating individuals with T2DM from 17 secondary health care institutions. Study participants were newly initiated with insulin therapy, being treated with basal or premix insulin ± oral antidiabetics (OAD) for 6-12 months.

resultsFour hundred one individuals were included in the study between October 2016 and March 2017. The mean age of study patients was 61.8 ± 9.2 years with mean BMI 30.0 ± 5.0 kg/m

conclusionsThe NEED study showed that new insulin users of either basal or premix HM insulin have many unmet needs in the first 6-12 months of treatment. This confirms that in real-life settings novel insulins should be considered in the management of T2DM to reduce the number of symptomatic hypoglycemic events and reach a better HbA1c level.

fundingSanofi, Serbia.

Indexed as

Basal insulinDiabetesPremix insulinType 2 diabetesUnmet needs

Identifiers

PMID30450529
PMCPMC6349298
OpenAlexW2900689749

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.